Association between neuropeptide Y gene polymorphism and antipsychotics effect.

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia pathogenesis is linked to Neuropeptide Y (NPY) gene variations.
• Understanding genetic factors influencing antipsychotic response is crucial for personalized treatment.

Purpose of the Study:

• To explore the relationship between specific NPY gene polymorphisms (rs16141, rs16145, rs5573) and antipsychotic treatment response in Chinese schizophrenia patients.

Main Methods:

• 228 Chinese Han patients with schizophrenia were genotyped for NPY polymorphisms.
• Antipsychotic efficacy was assessed using the Positive and Negative Syndrome Scale (PANSS) over 8 weeks.
• Statistical analyses included comparisons of allele/genotype distributions and genetic models.

Main Results:

• No significant associations were found between NPY gene polymorphisms (rs16141, rs16145, rs5573) and antipsychotic treatment response after Bonferroni correction.
• A potential association was noted for NPY rs5573 in a recessive model, but this did not reach statistical significance after correction.
• Haplotype analysis of rs16141 and rs5573 showed no significant differences between responders and non-responders.

Conclusions:

• This study did not establish a significant association between NPY gene polymorphisms (rs16141, rs16145, rs5573) and antipsychotic response in the studied Chinese population after correction.
• Further research is needed to fully elucidate the role of NPY gene variations in schizophrenia treatment efficacy.